Literature DB >> 24807086

Time intervals from subarachnoid hemorrhage to rebleed.

M R Germans1, B A Coert, W P Vandertop, D Verbaan.   

Abstract

The most threatening early complication and predictor of poor outcome after an aneurysmal subarachnoid hemorrhage (aSAH) is a rebleed. To evaluate what proportion of rebleeds might be prevented by early treatment, we assessed the time interval from the initial hemorrhage to rebleed, and the location of the patient at the time of rebleed. Patient characteristics, World Federation of Neurological Surgeons grade on admission and modified Rankin Scale outcome scores, referring hospitals and time intervals from initial hemorrhage to treatment of 293 patients treated between 2008 and 2011 were evaluated. Time intervals to rebleeds and location of the patients at the time of rebleed were retrieved. Rebleeds were confirmed by CT in 12% of patients, and an additional 4% of patients was diagnosed as having a possible rebleed. Sixty percent of rebleeds occurred after admission to the treatment center. Almost all rebleeds occurred within 24 h, with a median time interval between initial hemorrhage and rebleed of 180 min. A significantly shorter time to treatment and a higher mortality were seen in the group of patients with a rebleed. Approximately, one in six patients with an aSAH had a rebleed, of which a majority might have been preventable because they occurred after admission to the treatment center. A reduction in the rebleed rate seems feasible by securing the aneurysm as soon as possible by improving in-hospital logistics for early aneurysm treatment. Alternative options, such as immediate administration of antifibrinolytics, are being explored in a multicenter trial.

Entities:  

Mesh:

Year:  2014        PMID: 24807086     DOI: 10.1007/s00415-014-7365-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

2.  Treatment of ruptured aneurysms: earlier is better.

Authors:  Alexander G Weil; Ji-Zong Zhao
Journal:  World Neurosurg       Date:  2011-12-17       Impact factor: 2.104

3.  Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery.

Authors:  Y B Roos; L F Beenen; R J Groen; K W Albrecht; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

4.  Predictors of outcome in World Federation of Neurologic Surgeons grade V aneurysmal subarachnoid hemorrhage patients.

Authors:  René van den Berg; Mahrouz Foumani; Rosalie D Schröder; Saskia M Peerdeman; Janneke Horn; Shandra Bipat; W Peter Vandertop
Journal:  Crit Care Med       Date:  2011-12       Impact factor: 7.598

5.  Ultra-early (within 24 hours) aneurysm treatment after subarachnoid hemorrhage.

Authors:  George Kwok Chu Wong; Ronald Boet; Stephanie Chi Ping Ng; Matthew Chan; Tony Gin; Benny Zee; Wai Sang Poon
Journal:  World Neurosurg       Date:  2011-11-01       Impact factor: 2.104

6.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

7.  Aneurysmal rebleeding : factors associated with clinical outcome in the rebleeding patients.

Authors:  Ki Chul Cha; Jae Hoon Kim; Hee In Kang; Byung Gwan Moon; Seung Jin Lee; Joo Seung Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-02-28

8.  Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment.

Authors:  P J Lindsberg; O Häppölä; M Kallela; L Valanne; M Kuisma; M Kaste
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

Review 9.  European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage.

Authors:  Thorsten Steiner; Seppo Juvela; Andreas Unterberg; Carla Jung; Michael Forsting; Gabriel Rinkel
Journal:  Cerebrovasc Dis       Date:  2013-02-07       Impact factor: 2.762

Review 10.  Incidence, predisposing factors, management and survival following cardiac arrest due to subarachnoid haemorrhage: a review of the literature.

Authors:  Markus B Skrifvars; Michael J Parr
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-11-14       Impact factor: 2.953

View more
  12 in total

Review 1.  Stroke: an update.

Authors:  José M Ferro; Catarina Fonseca
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

2.  [Neurosurgical intensive care medicine : Intensive medical care studies from 2020/2021].

Authors:  C Beynon; M Bernhard; T Brenner; M Dietrich; M O Fiedler; C Nusshag; M A Weigand; C J Reuß; D Michalski; C Jungk
Journal:  Anaesthesist       Date:  2021-08-10       Impact factor: 1.041

3.  Early predictors of functional outcome in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Jordi de Winkel; Tim Y Cras; Ruben Dammers; Pieter-Jan van Doormaal; Mathieu van der Jagt; Diederik W J Dippel; Hester F Lingsma; Bob Roozenbeek
Journal:  BMC Neurol       Date:  2022-06-30       Impact factor: 2.903

4.  Desmopressin administration and rebleeding in subarachnoid hemorrhage: analysis of an observational prospective database.

Authors:  Charles L Francoeur; David Roh; J Michael Schmidt; Stephan A Mayer; M Cristina Falo; Sachin Agarwal; E Sander Connolly; Jan Claassen; Mitchell S V Elkind; Soojin Park
Journal:  J Neurosurg       Date:  2018-01-01       Impact factor: 5.115

Review 5.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Won-Sang Cho; Jeong Eun Kim; Sukh Que Park; Jun Kyeung Ko; Dae-Won Kim; Jung Cheol Park; Je Young Yeon; Seung Young Chung; Joonho Chung; Sung-Pil Joo; Gyojun Hwang; Deog Young Kim; Won Hyuk Chang; Kyu-Sun Choi; Sung Ho Lee; Seung Hun Sheen; Hyun-Seung Kang; Byung Moon Kim; Hee-Joon Bae; Chang Wan Oh; Hyeon Seon Park
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

6.  Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study.

Authors:  R Post; M R Germans; H D Boogaarts; B Ferreira Dias Xavier; R Van den Berg; B A Coert; W P Vandertop; D Verbaan
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

7.  Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.

Authors:  René Post; Menno R Germans; Bert A Coert; Gabriël J E Rinkel; W Peter Vandertop; Dagmar Verbaan
Journal:  Trials       Date:  2020-02-18       Impact factor: 2.279

Review 8.  The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lingxin Cai; Hanhai Zeng; Xiaoxiao Tan; Xinyan Wu; Cong Qian; Gao Chen
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

9.  The critical care management of poor-grade subarachnoid haemorrhage.

Authors:  Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald
Journal:  Crit Care       Date:  2016-01-23       Impact factor: 9.097

Review 10.  Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage.

Authors:  Airton Leonardo de Oliveira Manoel; R Loch Macdonald
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.